Felipe Gamboa is PhD in Pharmacology and Toxicology at the Complutense University of Madrid (Spain) with 15 years of experience divided into research and development of drugs in the pharmaceutical industry and teaching in the areas of pharmacology and toxicology. Felipe is an expert in assessment affects (therapeutic and toxic) of drugs particularly in the development of laboratory tests by HPLC, physico-chemical determination of raw materials, pharmacokinetic analysis, bioavailability and bioequivalence as mechanisms for assessing adulterated drugs by analysis of their efficacy, safety and purity. Felipe has worked as a global security drug specialist in Merck Sharp and Dohme and has served as Scientific Director of the Pharmaceutical Laboratory Provet. He is currently principal investigator at Kemtec in a private
Curriculum Vitae
Felipe Gamboa is PhD in Pharmacology and Toxicology at the Complutense University of Madrid (Spain) with 15 years of experience divided into research and development of drugs in the pharmaceutical industry and teaching in the areas of pharmacology and toxicology.
Felipe is an expert in assessment affects (therapeutic and toxic) of drugs particularly in the development of laboratory tests by HPLC, physico-chemical determination of raw materials, pharmacokinetic analysis, bioavailability and bioequivalence as mechanisms for assessing adulterated drugs by analysis of their efficacy, safety and purity.
Felipe has worked as a global security drug specialist in Merck Sharp and Dohme and has served as Scientific Director of the Pharmaceutical Laboratory Provet. He is currently principal investigator at Kemtec in a private project of development of drugs enhanced through nanotechnology and teaches pharmacology, pharmaceutical chemistry and toxicology to undergraduate and graduate students at the University UDCA and la Salle University.
High Risk for Human Life: Drug Counterfeiting
Wayne Roberts
Pfizer Inc. USA
Felipe Gamboa
Colombia
